Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sirtuin 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | jmjC domain containing protein | 0.006 | 0.1518 | 0.1625 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0031 | 0.0139 | 0.0568 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.6544 | 1 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0052 | 0.1158 | 0.166 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.6544 | 1 |
Giardia lamblia | NAD-dependent histone deacetylase Sir2 | 0.0151 | 0.5753 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0031 | 0.0139 | 0.0081 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0213 | 0.863 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.4828 | 0.5522 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 0.5 |
Echinococcus granulosus | NAD dependent deacetylase sirtuin 1 | 0.0151 | 0.5753 | 0.8776 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.006 | 0.1518 | 0.2217 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.008 | 0.2442 | 1 |
Echinococcus multilocularis | geminin | 0.0168 | 0.6544 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 0.5 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 0.3596 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.0052 | 0.1158 | 0.4744 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 0.5 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.008 | 0.2442 | 0.3596 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0101 | 0.3435 | 0.5147 |
Plasmodium vivax | SET domain protein, putative | 0.0031 | 0.0139 | 0.0568 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0105 | 0.362 | 0.5473 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.008 | 0.2442 | 1 |
Brugia malayi | NAD-dependent deacetylase SIRT1 | 0.0151 | 0.5753 | 0.6612 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0052 | 0.1158 | 0.1592 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.008 | 0.2442 | 1 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.0052 | 0.1158 | 0.5 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 0.5 |
Brugia malayi | Probable ClpP-like protease | 0.008 | 0.2442 | 0.2712 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.2442 | 0.2712 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.006 | 0.1518 | 0.2154 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.008 | 0.2442 | 1 |
Brugia malayi | jmjC domain containing protein | 0.006 | 0.1518 | 0.1625 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 0.3648 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.5753 | 0.6612 |
Echinococcus granulosus | geminin | 0.0168 | 0.6544 | 1 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.006 | 0.1518 | 0.2154 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 1 |
Echinococcus multilocularis | NAD dependent deacetylase sirtuin 1 | 0.0151 | 0.5753 | 0.8766 |
Brugia malayi | Pre-SET motif family protein | 0.0213 | 0.863 | 1 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.006 | 0.1518 | 0.2217 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 1 |
Trichomonas vaginalis | set domain proteins, putative | 0.0242 | 1 | 1 |
Schistosoma mansoni | jumonji domain containing protein | 0.006 | 0.1518 | 0.2154 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.006 | 0.1518 | 0.2154 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0105 | 0.362 | 0.5436 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.0151 | 0.5753 | 0.8766 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.006 | 0.1518 | 0.1625 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.2442 | 0.5 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.0052 | 0.1158 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.006 | 0.1518 | 0.2154 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | 0 | Activation of SIRT1 in human U2OS cells assessed as decrease in deacetylation level at 10 uM | ChEMBL. | 18046409 |
Activity (binding) | 0 | Activation of human SIRT1 (unknown origin) assessed as decrease in Km of enzyme for acetylated peptide substrate by mass spectrometry assay | ChEMBL. | 18046409 |
Activity (binding) | = 271 % | Activation of human SIRT1 expressed in Escherichia coli BL21Start assessed as maximum activation of enzyme activity by mass spectrometry assay | ChEMBL. | 19199480 |
Activity (binding) | = 447 % | Activation of human SIRT1 expressed in Escherichia coli BL21 by mass spectrometry assay | ChEMBL. | 18046409 |
Activity (binding) | = 447 % | Activation of human SIRT1 expressed in Escherichia coli BL21 by mass spectrometry assay | ChEMBL. | 18046409 |
Activity (binding) | = 1.8 uM | Activation of human SIRT1 expressed in Escherichia coli BL21Start assessed as concentration required to increase 50% enzyme activity by mass spectrometry assay | ChEMBL. | 19199480 |
AUC (ADMET) | = 45000 ng.hr/ml | AUC in C57BL/6 mouse at 100 mg/kg, po or 10 mg/kg, iv | ChEMBL. | 19199480 |
Cmax (ADMET) | = 14 uM | Cmax in C57BL/6 mouse at 100 mg/kg, po or 10 mg/kg, iv | ChEMBL. | 19199480 |
EC50 (binding) | = 1.8 uM | Activation of N-terminal His6-tagged SIRT1 (156 to 664 amino acid residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using ac-RHKKac-AMC as substrate after 45 mins by fluorometric analysis | ChEMBL. | 23316803 |
EC50 (binding) | = 2.9 uM | Activation of human SIRT1 expressed in Escherichia coli BL21 by mass spectrometry assay | ChEMBL. | 18046409 |
EC50 (binding) | = 2.9 uM | Activation of human SIRT1 expressed in Escherichia coli BL21 by mass spectrometry assay | ChEMBL. | 18046409 |
EC50 (binding) | > 300 uM | Activation of SIRT2 (unknown origin) by mass spectrometry assay | ChEMBL. | 18046409 |
EC50 (binding) | > 300 uM | Activation of SIRT3 (unknown origin) by mass spectrometry assay | ChEMBL. | 18046409 |
EC50 (binding) | > 300 uM | Activation of SIRT2 (unknown origin) by mass spectrometry assay | ChEMBL. | 18046409 |
EC50 (binding) | > 300 uM | Activation of SIRT3 (unknown origin) by mass spectrometry assay | ChEMBL. | 18046409 |
F (ADMET) | = 40 % | Oral bioavailability in C57BL/6 mouse at 100 mg/kg | ChEMBL. | 19199480 |
Kd (binding) | = 16.2 uM | Binding affinity to human SIRT1 by isothermal titration calorimetry | ChEMBL. | 18046409 |
Kd (binding) | = 16.2 uM | Binding affinity to human SIRT1 by isothermal titration calorimetry | ChEMBL. | 18046409 |
Kd (binding) | = 16.2 uM | Binding affinity to SIRT1 | ChEMBL. | 19199480 |
max activation (binding) | = 271 % | Activation of N-terminal His6-tagged SIRT1 (156 to 664 amino acid residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using ac-RHKKac-AMC as substrate at 50 uM after 45 mins by fluorimetric analysis relative to control | ChEMBL. | 23316803 |
T1/2 (ADMET) | = 6 hr | Terminal half life in C57BL/6 mouse at 100 mg/kg, po or 10 mg/kg, iv | ChEMBL. | 19199480 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.